Numis Securities Ltd Reiterates Buy Rating for NMC Health PLC (NMC)
NMC Health PLC (LON:NMC)‘s stock had its “buy” rating reiterated by equities research analysts at Numis Securities Ltd in a research note issued to investors on Tuesday. They currently have a GBX 620 ($10.36) price objective on the stock. Numis Securities Ltd’s target price indicates a potential upside of 29.17% from the company’s current price.
Shares of NMC Health PLC (LON:NMC) opened at 476.00 on Tuesday. NMC Health PLC has a one year low of GBX 308.30 and a one year high of GBX 546.50. The stock has a 50-day moving average of GBX 466.9 and a 200-day moving average of GBX 479.2. The company’s market cap is £884.0 million.
Separately, analysts at Canaccord Genuity reiterated a “buy” rating on shares of NMC Health PLC in a research note on Friday, June 27th. They now have a GBX 620 ($10.36) price target on the stock.
NMC Health plc is a United Arab Emirates-based healthcare provider. It operates in two segments: healthcare, which includes two segments: Healthcare and Distribution & services.
Receive News & Ratings for NMC Health PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NMC Health PLC and related companies with Analyst Ratings Network's FREE daily email newsletter.